Provided here are links that highlight relevant milestones and news for Juvabis.

For more up-to-date information, please visit our LinkedIn profile.

A very promising new antibiotic just started clinical trials

Researchers from ENABLE are hopeful about EBL-1003 because it has passed the stage at which most potential antibiotics fail.